Late-stage diversification of rewired purine C-nucleosides reveals potent antitrypanosomatid agents with in vivo efficacy
Source
Journal of medicinal chemistry - ISSN 0022-2623-69:16 (2026) p. 19744-19758
Selective and orally bioavailable dipeptidyl peptidase 9 inhibitors with potent pyroptosis induction properties
Source
Journal of medicinal chemistry - ISSN 0022-2623-68:21 (2025) p. 23163-23184
In vivo bioluminescence imaging reveals differences in Leishmania infantum parasite killing kinetics by antileishmanial reference drugs
Source
ACS Infectious Diseases - ISSN 2373-8227-10:6 (2024) p. 2101-2107
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc₁
Source
Science translational medicine - ISSN 1946-6234-15:726 (2023) p.
Highly selective inhibitors of dipeptidyl peptidase 9 (DPP9) derived from the clinically used DPP4-inhibitor vildagliptin
Source
Journal of medicinal chemistry - ISSN 1520-4804-66:18 (2023) p. 12717-12738